Health Care & Life Sciences » Biotechnology | NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc.
Stock Exchange NYSE
EPS
$0.54
Market Cap
$31.63 M
Shares Outstanding
19.17 M
Public Float
5.15 M

Profile

Address
2000 Powell Street
Emeryville California 94608
United States
Employees -
Website http://novabay.com
Updated 07/08/2019
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in commercializing and developing products for eye care. Its products include Avenova, NeutroPhase, and CelleRx. The comapny was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.

Financials

View All

Mark M. Sieczkarek
Chairman, President & Chief Executive Officer
Yan Bin Liu
Non-Independent Director